Nova Biomedical Advances Integrated Cell Line Development Workflows: NanoCellect products are now part of Nova Biomedical

Contributed by: PR Newswire

Tags

Nova-Biomedical-acq

More Like This

PR Newswire associated0

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

PR Newswire associated0

Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation

Leadgene Biosolutions Expands Its Product Portfolio Following Strategic Integration, Advancing Early-Stage Mixing and Long-Term Metabolic Insight

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

Bracco Expands BubbleGen Cell Selection with CD3+ T Cell Isolation Kit

PR Newswire associated0

Patricia Industries' subsidiary Advanced Instruments to acquire and merge with Nova Biomedical

EmeraNova seeks partners around the world to bring promising technologies to market quickly and equip clinicians with advanced, effective solutions.

BioLab Holdings Launches EmeraNova™ to Advance the Future of Tissue Restoration

Bracco Launches BubbleGen™ Early Access Program for Microbubble-Based Cell Selection and Activation at ISCT